Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9030880rdf:typepubmed:Citationlld:pubmed
pubmed-article:9030880lifeskim:mentionsumls-concept:C0038170lld:lifeskim
pubmed-article:9030880lifeskim:mentionsumls-concept:C0038172lld:lifeskim
pubmed-article:9030880lifeskim:mentionsumls-concept:C0231335lld:lifeskim
pubmed-article:9030880lifeskim:mentionsumls-concept:C0021758lld:lifeskim
pubmed-article:9030880lifeskim:mentionsumls-concept:C0011615lld:lifeskim
pubmed-article:9030880lifeskim:mentionsumls-concept:C0021745lld:lifeskim
pubmed-article:9030880lifeskim:mentionsumls-concept:C0206527lld:lifeskim
pubmed-article:9030880lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:9030880lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:9030880lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:9030880lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:9030880lifeskim:mentionsumls-concept:C0033268lld:lifeskim
pubmed-article:9030880lifeskim:mentionsumls-concept:C1514485lld:lifeskim
pubmed-article:9030880pubmed:issue2lld:pubmed
pubmed-article:9030880pubmed:dateCreated1997-3-11lld:pubmed
pubmed-article:9030880pubmed:abstractTextWe have examined the cell-mediated immunity (CMI) to Staphylococcus aureus (S. aureus) and Staphylococcal enterotoxin B (SEB) in peripheral blood mononuclear cells (PBMC) from children with atopic dermatitis (AD) and from non-atopic child controls by measurement of proliferative responses and production of the cytokines IFN-gamma and IL-4. PBMC from children with AD showed significantly higher proliferative responses to both S. aureus (P < 0.01) and SEB (P < 0.05). Despite this enhanced proliferation, production of IFN-gamma in response to S. aureus (P < 0.001) and SEB (P < 0.01) from these PBMC was significantly diminished. In contrast, PBMC from children with AD were significantly more likely to produce IL-4 in response to S. aureus (P < 0.01). These findings demonstrate in vitro heightened CMI to S. aureus in children with AD, and implicate S. aureus as a potent inflammatory stimulant. Impaired IFN-gamma production to S. aureus in vivo may result in failure to eradicate S. aureus from skin. The organism's persistence on skin would contribute to inflammation by causing continued T cell activation and release of pro-inflammatory mediators.lld:pubmed
pubmed-article:9030880pubmed:languageenglld:pubmed
pubmed-article:9030880pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9030880pubmed:citationSubsetIMlld:pubmed
pubmed-article:9030880pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9030880pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9030880pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9030880pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9030880pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9030880pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9030880pubmed:statusMEDLINElld:pubmed
pubmed-article:9030880pubmed:monthFeblld:pubmed
pubmed-article:9030880pubmed:issn0009-9104lld:pubmed
pubmed-article:9030880pubmed:authorpubmed-author:CampbellD EDElld:pubmed
pubmed-article:9030880pubmed:authorpubmed-author:KempA SASlld:pubmed
pubmed-article:9030880pubmed:issnTypePrintlld:pubmed
pubmed-article:9030880pubmed:volume107lld:pubmed
pubmed-article:9030880pubmed:ownerNLMlld:pubmed
pubmed-article:9030880pubmed:authorsCompleteYlld:pubmed
pubmed-article:9030880pubmed:pagination392-7lld:pubmed
pubmed-article:9030880pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:9030880pubmed:meshHeadingpubmed-meshheading:9030880-...lld:pubmed
pubmed-article:9030880pubmed:meshHeadingpubmed-meshheading:9030880-...lld:pubmed
pubmed-article:9030880pubmed:meshHeadingpubmed-meshheading:9030880-...lld:pubmed
pubmed-article:9030880pubmed:meshHeadingpubmed-meshheading:9030880-...lld:pubmed
pubmed-article:9030880pubmed:meshHeadingpubmed-meshheading:9030880-...lld:pubmed
pubmed-article:9030880pubmed:meshHeadingpubmed-meshheading:9030880-...lld:pubmed
pubmed-article:9030880pubmed:meshHeadingpubmed-meshheading:9030880-...lld:pubmed
pubmed-article:9030880pubmed:meshHeadingpubmed-meshheading:9030880-...lld:pubmed
pubmed-article:9030880pubmed:meshHeadingpubmed-meshheading:9030880-...lld:pubmed
pubmed-article:9030880pubmed:meshHeadingpubmed-meshheading:9030880-...lld:pubmed
pubmed-article:9030880pubmed:meshHeadingpubmed-meshheading:9030880-...lld:pubmed
pubmed-article:9030880pubmed:meshHeadingpubmed-meshheading:9030880-...lld:pubmed
pubmed-article:9030880pubmed:meshHeadingpubmed-meshheading:9030880-...lld:pubmed
pubmed-article:9030880pubmed:meshHeadingpubmed-meshheading:9030880-...lld:pubmed
pubmed-article:9030880pubmed:year1997lld:pubmed
pubmed-article:9030880pubmed:articleTitleProliferation and production of interferon-gamma (IFN-gamma) and IL-4 in response to Staphylococcus aureus and staphylococcal superantigen in childhood atopic dermatitis.lld:pubmed
pubmed-article:9030880pubmed:affiliationDepartment of Immunology, Royal Children's Hospital, Melbourne, Australia.lld:pubmed
pubmed-article:9030880pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9030880pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9030880lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9030880lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9030880lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9030880lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9030880lld:pubmed